GREY:MYLGF - Post by User
Comment by
pepmanon Jan 20, 2010 10:23pm
![](https://assets.stockhouse.com/kentico-cms/0342-00/images/Sprite.svg#id_Post_Views_Icon)
149 Views
Post# 16702335
RE: RE: Dundee biotech outlook sees ‘ample room fo
RE: RE: Dundee biotech outlook sees ‘ample room foThe two phase I studies on MGCD265 are expected to end in March. Results should follow in June at ASCO. The phase I/II combo trial should be completed only in 2011.